Search
  1. Home
  2. Southern Africa
  3. South Africa

Thembalami licensed to supply antiretrovirals

    JOHANNESBURG

    After being granted a voluntary licence, pharmaceutical company Thembalami will now make and sell cheap generic AIDS drugs.

    The licence, issued by pharmaceutical giants GlaxoSmithKline (GSK) and Boehringer Ingelheim, allows the South African company to make and sell generic copies of patented antiretroviral drugs in sub-Saharan Africa.

    GSK told the Panafrican News Agency that the measure was intended to help the world's poorest countries to meet the unique challenges of HIV/AIDS, in areas of the world hardest hit by the pandemic.

    The two companies added that they were in negotiations to issue further voluntary licences for their anti-AIDS drugs.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join